News Release

Design, analyses of oncology trials during COVID-19 pandemic

Peer-Reviewed Publication

JAMA Network

What The Viewpoint Says: The challenges associated with conducting and assessing results of clinical trials during the COVID-19 pandemic are discussed in this Viewpoint.

Authors: Chaya S. Moskowitz, Ph.D., of the Memorial Sloan Kettering Cancer Center in New York, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link 


Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.